# ScoreItem: Low carb

**ID:** `c77cedd3-2800-70de-bec4-0b5534637c78`
**FullName:** Low carb (Alimenta√ß√£o - Atual (√∫ltmos 6 meses) - Padr√£o alimentar atual)

**Preparation Metadata:**
- Quality Grade: **EXCELLENT**
- Total Chunks: 30 de 7 artigos
- Avg Similarity: 0.700

---

## Contexto

Voc√™ √© um especialista em medicina funcional integrativa e est√° contribuindo com o **Escore Plenya** ‚Äî um escore completo de an√°lise de sa√∫de que avalia todos os aspectos da sa√∫de, performance e longevidade humana. Cada ScoreItem representa um par√¢metro cl√≠nico, laboratorial, gen√©tico, comportamental ou hist√≥rico que comp√µe esse escore.

Seu papel √© gerar conte√∫do cl√≠nico de alta qualidade para enriquecer cada par√¢metro do escore com relev√¢ncia cl√≠nica, orienta√ß√£o ao paciente e conduta pr√°tica.

**Regras inegoci√°veis:**
- Use **apenas** o conhecimento m√©dico real consolidado e os dados presentes nos chunks cient√≠ficos abaixo
- **N√£o alucine, n√£o invente** dados, estudos, estat√≠sticas ou refer√™ncias que n√£o estejam nos chunks ou no seu conhecimento m√©dico estabelecido
- Se um dado espec√≠fico n√£o constar nos chunks e n√£o for do seu conhecimento consolidado, **n√£o o inclua**
- Seja preciso: prefira omitir a inventar

## Instru√ß√£o

Com base nos chunks cient√≠ficos abaixo, gere as respostas em formato JSON.

**O JSON deve obrigatoriamente conter o campo `score_item_id` com o valor `c77cedd3-2800-70de-bec4-0b5534637c78`.**

```json
{
  "score_item_id": "c77cedd3-2800-70de-bec4-0b5534637c78",
  "clinical_relevance": "Texto t√©cnico para m√©dicos (1000-5000 chars): defini√ß√£o fisiol√≥gica precisa, valores de refer√™ncia e interpreta√ß√£o, fisiopatologia resumida, dados epidemiol√≥gicos com n√∫meros concretos, estratifica√ß√£o de risco baseada em evid√™ncias.",
  "points": 0,
  "patient_explanation": "Texto simples para pacientes (500-1000 chars): o que √© este par√¢metro sem jarg√µes, por que √© importante para a sa√∫de, o que valores alterados podem significar. Tom tranquilizador e educativo.",
  "conduct": "Conduta cl√≠nica em Markdown (1000-5000 chars): investiga√ß√£o complementar necess√°ria, crit√©rios de encaminhamento a especialistas, interven√ß√µes baseadas em evid√™ncias. Use bullet points, se√ß√µes e negrito."
}
```

**Nota:** `points` deve ser `0` neste item ‚Äî n√£o calcule pontua√ß√£o.

---

### Contexto Cient√≠fico

**ScoreItem:** Low carb (Alimenta√ß√£o - Atual (√∫ltmos 6 meses) - Padr√£o alimentar atual)

**30 chunks de 7 artigos (avg similarity: 0.700)**

### Chunk 1/30
**Article:** Dieta Cetog√™nica - Parte II (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.789

o e estilo de vida
   - Efetividade depende da manuten√ß√£o: resultados superiores durante interven√ß√£o; ao cessar, h√° tend√™ncia √† recupera√ß√£o de peso; foco em estilo de vida (menos ultraprocessados, carboidratos de melhor qualidade).
* Cetoadapta√ß√£o e dura√ß√£o m√≠nima de estudos
   - Cetoadapta√ß√£o ~6 semanas; estudos robustos n√£o devem durar menos de 8 semanas; idealizar dura√ß√µes adequadas para avaliar efeitos.
## ‚ùì Perguntas
- [Inserir Pergunta/Confus√£o]
## üìö Tarefas
- [ ] 1. Oferecer dieta low carb ou cetog√™nica como op√ß√£o terap√™utica para pacientes com diabetes tipo 2, especialmente com HbA1c entre 6,5% e 9%.
- [ ] 2. Em protocolos hipocal√≥ricos, ajustar prote√≠na para ‚â•1 g/kg/dia (prefer√™ncia 1,2 g/kg/dia) visando preservar/ganhar massa magra.
- [ ] 3. Monitorar lipidograma completo, incluindo subfracionamento (resson√¢ncia de part√≠culas) em pacientes com poss√≠vel aumento de LDL na fase inicial.
- [ ] 4.

---

### Chunk 2/30
**Article:** √Åcidos Graxos Saturados de Cadeia Longa I (2024)
**Journal:** Pos Graduacao MFI
**Section:** discussion | **Similarity:** 0.782

e planejar substitui√ß√µes iniciais por fontes de gordura/prote√≠na para aumentar saciedade.
- [ ] 2. Monitorar marcadores cardiometab√≥licos (peso, IMC, circunfer√™ncia abdominal, PA, TG, glicemia, HbA1c, insulina, PCR, HDL) ap√≥s interven√ß√£o de baixo carboidrato por 8‚Äì12 semanas.
- [ ] 3. Implementar ciclagem de estrat√©gias alimentares e variar tipos de gorduras (curtas, m√©dias, monoinsaturadas) ap√≥s a fase inicial de perda de peso, evitando estagna√ß√£o e excesso cal√≥rico.
- [ ] 4. Revisar literatura-chave: metan√°lises de 2012 (baixo carboidrato), 2014 (gorduras saturadas vs. poliinsaturados) e revis√£o de 2021 (comprimento de cadeia e efeitos), destacando vieses de publica√ß√£o.
- [ ] 5. Educar o paciente sobre densidade energ√©tica de alimentos ricos em gordura (queijos, bacon) e ajustar por√ß√µes conforme o metabolismo basal diminui com a perda de peso.
- [ ] 6.

---

### Chunk 3/30
**Article:** Emagrecimento - Parte IV (2024)
**Journal:** Pos Graduacao MFI
**Section:** discussion | **Similarity:** 0.772

cas de ajuste‚Äù.
> - Tabela de densidade cal√≥rica vs. saciedade de alimentos low carb comuns.
> - Exemplo num√©rico refor√ßando que low carb n√£o isenta controle cal√≥rico.
> - Di√°rio de 3 dias focado em por√ß√µes de ‚Äúlow carb cal√≥ricos‚Äù para revis√£o em grupo.
### 8. Evid√™ncias para low carb/very low carb na remiss√£o do diabetes
- Revis√£o sistem√°tica e meta-an√°lise (2021) sustenta efic√°cia e seguran√ßa de very low carb na remiss√£o do diabetes.
- Na pr√°tica, melhora da qualidade alimentar e calorias adequadas determinam resultados, apesar do potencial est√≠mulo insulin√™mico da prote√≠na.
- Estrat√©gia: iniciar maioria dos pacientes em low carb com ajustes individualizados.
> Sugest√µes de IA
> - Incluir crit√©rios de remiss√£o (HbA1c, glicemia, suspens√£o de medica√ß√£o).
> - Contraindica√ß√µes e precau√ß√µes (DM1, SGLT2, cetoacidose, gestantes).
> - Algoritmo inicial (carboidratos/dia, metas de prote√≠na, fontes de gordura).
### 9.

---

### Chunk 4/30
**Article:** √Åcidos Graxos Saturados de Cadeia Longa I (2024)
**Journal:** Pos Graduacao MFI
**Section:** discussion | **Similarity:** 0.720

o incluir estudos n√£o publicados, apontando poss√≠vel vi√©s de publica√ß√£o.
- Ano de refer√™ncia (2014) em que a revis√£o sugeria mudan√ßa de diretrizes cardiovasculares, criticando a falta de atualiza√ß√£o.
**Dietas de baixo carboidrato mostram melhorias cardiometab√≥licas consistentes, incluindo aumento de HDL, em amostras cl√≠nicas relevantes.**
- Meta-an√°lise de 2012 sobre dietas de baixo carboidrato: incluiu 1.141 pacientes obesos e reportou melhorias em diversos desfechos cardiometab√≥licos.
- Entre os desfechos positivos, destaque para aumento de HDL, componente do perfil lip√≠dico relevante ao risco cardiovascular.
- Evid√™ncias contextualizam redu√ß√£o de risco atrav√©s da diminui√ß√£o de carboidratos, oferecendo alternativa √†s recomenda√ß√µes centradas em restri√ß√£o gen√©rica de gorduras.

---

### Chunk 5/30
**Article:** Dose-dependent effect of carbohydrate restriction for type 2 diabetes management: a systematic review and dose-response meta-analysis of randomized controlled trials (2026)
**Journal:** Revista n√£o identificada
**Section:** results | **Similarity:** 0.713

n,increasingtheconsumptionofplant-basedproteins(96)andsubstitutingplant-basedproteinsforanimal-basedproteins(97)couldimproveserumlipidproles.However,trialsincludedinthepresentreviewdidnotreportsufcientinformationaboutpotential
changesintheconsumptionofsubtypesofdietaryproteinovertheinterventionduration.TherewasalsoaU-shapedeffectonbodyweightatthe12-monthfollow-up,withanupwardcurveatacarbohydrateintakelessthan35%.TheU-shapedeffectmaybeduetoadecreaseinadherencetotheprescribeddiets,alongwiththeincrease
inthedegreeofcarbohydraterestriction.OurU-shapedeffectwasconsistentwiththeresultsofarecentmeta-analysisofrandomizedtrialsdemonstratingtrivialandnonsignicanteffects
oflow-carbohydratediets(<26%)onbodyweightatthe12-monthfollow-up(8).However,theanalysisofTGindicatedasomewhatoppositending,wheretherewasalinearreduction
	
	
Getulio Jos√© Mattos Do Amaral Filho - getfilho@yahoo.com.br - CPF: 034.983.039-88

Carbohydraterestrictionindiabetes51inTGatthe

---

### Chunk 6/30
**Article:** √Åcidos Graxos Saturados de Cadeia Longa I (2024)
**Journal:** Pos Graduacao MFI
**Section:** methods | **Similarity:** 0.713

-carb associadas a redu√ß√£o de peso, IMC, circunfer√™ncia abdominal, PA, TG, glicemia, HbA1c, insulina, PCR; aumento de HDL.
- Interpreta√ß√£o: maioria erra por excesso de carboidratos; reduzir carboidratos de baixa qualidade tende a melhorar marcadores cardiometab√≥licos.
- Pr√°tica cl√≠nica: avaliar padr√£o alimentar t√≠pico (caf√© com p√£es/cereais; lanches variados; jantar hiperpalat√°vel), identificar o principal erro e come√ßar por ele.
> **Sugest√µes de IA**
> - Organiza√ß√£o: Voc√™ conectou bem evid√™ncia a triagem diet√©tica; sugira um instrumento breve (recordat√≥rio de 24h + checklist de ultraprocessados) para padronizar a anamnese.
> - M√©todos: Simule entrevistas com alunos ‚Äúpacientes‚Äù para praticar identifica√ß√£o do ‚Äúerro principal‚Äù.
> - Clareza: Enfatize que ‚Äúlow-carb‚Äù n√£o significa zero carboidrato; destaque qualidade e timing (√≠ndice glic√™mico/carga).
> - Melhoria: Proponha metas SMART (p.

---

### Chunk 7/30
**Article:** Effect of the ketogenic diet on glycemic control, insulin resistance, and lipid metabolism in patients with T2DM: a systematic review and meta-analysis (2026)
**Journal:** Revista n√£o identificada
**Section:** discussion | **Similarity:** 0.708

t(VLCKD):15g/daycarbohydrates,72‚Äì80g/dayproteins,23‚Äì24g/daylipids47.7¬±11.250.8¬±6.2NotspeciedScreeningADA,199810Saslow(2014)35USA1536Low-carbohydrate,ketogenic(LCK)diet:20‚Äì50g/daycarbohydrates.‚â•1836.2¬±8.2NotspeciedSelf-reportDiabetes
medication11Saslow(2017)9USA1648Low-carbohydrateketogenic(LCK)diet:20‚Äì50g/daycarbohydrates.‚â•1835.9(32.5,39.2)NotspeciedSelf-report,Diabetesmedication12Walton15USA1113Low-carbohydrate(LC)ketogenicdiet:5%carbohydrate(carbohydrate<30g/day),20‚àí25%protein,70‚àí75%fat.38.3¬±2.636.3¬±1.4‚â§1Self-reporthospitaldiagnosis13Hussain4Kuwait7824Low-carbohydrateketogenicdiet(LCKD):20g/daycarbohydrate.37.2¬±0.440.0¬±0.7NotspeciedSelf-report,FPGNnumberofparticipantsrecruitedinthestudy.Yuanetal.NutritionandDiabetes          (2020) 10:38 Page3of8NutritionandDiabetes
	
	
Getulio Jos√© Mattos Do Amaral Filho - getfilho@yahoo.com.br - CPF: 034.983.039-88

analysis.Fromtheperspectiveofglucosemetabolism,lipidmetabolis

---

### Chunk 8/30
**Article:** Dose-dependent effect of carbohydrate restriction for type 2 diabetes management: a systematic review and dose-response meta-analysis of randomized controlled trials (2026)
**Journal:** Revista n√£o identificada
**Section:** discussion | **Similarity:** 0.704

dicatedthatevenamodest(10%)decreaseincarbohydrate
intakecanexertsignicantimprovementincardiometabolicoutcomes,withhigherrestrictionindicatingmorefavorableeffects.A10%decreaseincarbohydrateintake,whichisequalto
50g/dina2000-kcal/ddiet,canbeeasilyusedtodevelopsimpleandeasy-to-understandmessagesforuseinpatientswithtype2diabetes.Wehadnoevidenceregardingtheeffectsofvery-low-carbohydratediets(‚â§10%).Arecentsystematicreviewindicatedthattrialswithavery-low-carbohydratediet(‚â§10%)andwithhighlyadherentpatientsreportedgreaterweightlossincomparisonwithlow-carbohydratediets(26%to11%)atthe6-monthfollow-up(8).However,duetoinsufcientdataregardingcarbohydratepercentagesineithertheinterventionorcontrolgroupswewereunabletoincludevery-low-carbohydrateorketogenicdietsinourdose-responsemeta-analysis.Inaddition,
accordingtocurrentrecommendations,very-low-carbohydratedietsaregenerallydenedasdietswith‚â§10%or<50g/dcarbohydrateintakes(31,32).Of11trialsthatimplementedavery-low-carbohydratediet(basedonacarbo

---

### Chunk 9/30
**Article:** Bases Metab√≥licas das Doen√ßas Cr√¥nicas e Gerenciamento - Glica√ß√£o 2 (2024)
**Journal:** Pos Graduacao MFI
**Section:** other | **Similarity:** 0.703

justar qualidade dos carboidratos.
  - Fun√ß√£o renal antes de iniciar/ajustar metformina.
- Plano de Tratamento e Seguimento:
  - Interven√ß√£o alimentar:
    - Reduzir carga glic√™mica; evitar carboidratos simples isolados; combinar com vegetais e prote√≠na.
    - Evitar preparos em alta temperatura que geram crostas/carboniza√ß√£o (p√£es muito tostados, carnes com ‚Äúcasquinha‚Äù preta, batata/mandioca/inhame fritos muito torrados).
    - Se em padr√£o paleo/low carb com excesso de gorduras saturadas, migrar para modelo mais mediterr√¢neo (mais peixes, carnes brancas, leguminosas; reduzir queijos/carnes vermelhas).
    - Em mulheres com constipa√ß√£o em low carb: aumentar vegetais de baixo amido e fibras, reduzir carne vermelha; manter carboidratos dentro de metas individuais.
  - Estilo de vida:
    - Aumentar atividade f√≠sica regular; metas personalizadas de composi√ß√£o corporal e peso adequado.
    - Reduzir ultraprocessados, bebidas a√ßucaradas e tabagismo.

---

### Chunk 10/30
**Article:** Dose-dependent effect of carbohydrate restriction for type 2 diabetes management: a systematic review and dose-response meta-analysis of randomized controlled trials (2026)
**Journal:** Revista n√£o identificada
**Section:** results | **Similarity:** 0.703

rencesbetweenstudiesathighriskofbiasandthoseatlowriskofbias.Here,wereportedresultsfromstudiesatlowriskofbias.trials,carbohydrateintakewasreportedasarangeeitherintheinterventionorinthecontrolarm;therefore,weusedthemidpointoftherangeasthepercentageofcarbohydrateintakefortheanalyses(53,57,59,60,79,92).In9trials,carbohydrateintakewasreportedintheformofgramsperday;thus,weconvertedthedatato%calorieusingtheaveragecalorieintakesreportedinthosetrials(48,49,57,58,70,80,81,87,89).Twentytrials(40%)wereratedtohavealowriskofbias(44,45,48,50,54‚Äì56,62,63,70,76,78‚Äì84,87,93),9(18%)wereratedtohavesomeconcerns(52,53,60,67‚Äì69,74,85,90),and21(42%)wereratedtohaveahighriskofbias(46,47,49,51,57‚Äì59,61,64‚Äì66,71‚Äì73,75,77,86,88,89,91,92)(SupplementalTable4).PrimaryoutcomeAtthe6-monthfollow-up,each10%reductionincarbohydrateintake,comparedwithacarbohydrateintakebetween55%‚Äì65%andthroughamaximumreductiondownto10%,reducedHbA1cby0.20%(95%CI,‚àí0.27%to‚àí0.13%;n=29trialswith2461participants;GRADE=highcertai

---

### Chunk 11/30
**Article:** Dose-dependent effect of carbohydrate restriction for type 2 diabetes management: a systematic review and dose-response meta-analysis of randomized controlled trials (2026)
**Journal:** Revista n√£o identificada
**Section:** discussion | **Similarity:** 0.702

ypatternsonglycemiccontrol,cardiovascular
riskfactors,andweightlossinpatientswithtype2diabetes:Anetworkmeta-analysis.JEvidBasedMed2019;12(1):29‚Äì39.13.SchwingshacklL,ChaimaniA,HoffmannG,SchwedhelmC,BoeingH.Anetworkmeta-analysisonthecomparativeefcacyofdifferentdietaryapproachesonglycaemiccontrolinpatientswithtype2diabetesmellitus.EurJEpidemiol2018;33(2):157‚Äì70.14.SilveriiG,BotarelliL,DicembriniI,GirolamoV,SantagiulianaF,MonamiM,MannucciE.Low-carbohydratedietsandtype2diabetestreatment:Ameta-analysisofrandomizedcontrolledtrials.ActaDiabetol2020;57(11):1375‚Äì82.15.vanZuurenEJ,FedorowiczZ,KuijpersT,PijlH.Effectsoflow-carbohydrate-comparedwithlow-fat-dietinterventionsonmetaboliccontrolinpeoplewithtype2diabetes:AsystematicreviewincludingGRADEassessments.AmJClinNutr2018;108(2):300‚Äì31.16.YuanX,WangJ,YangS,GaoM,CaoL,LiX,HongD,TianS,SunC.Effectoftheketogenicdietonglycemiccontrol,insulinresistance,andlipidmetabolisminpatientswithT2DM:Asystematicreviewandmeta-analysis.NutrDiabetes2020;10(1):

---

### Chunk 12/30
**Article:** Dieta Cetog√™nica - Parte II (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.701

um intermitente zeraram o score de severidade dos sintomas.
### Achados Adicionais Chave
- Uma meta-an√°lise de 14 ensaios cl√≠nicos incluiu 734 participantes com sobrepeso e obesidade, dos quais 444 eram diab√©ticos e 290 n√£o diab√©ticos.
- Outra revis√£o sistem√°tica e meta-an√°lise sobre diabetes tipo 2 avaliou 13 estudos com um total de 567 participantes.
- O efeito t√©rmico da prote√≠na, que converte 25% de suas calorias em calor, √© um mecanismo que contribui para a perda de peso em dietas com maior teor proteico.

---

## SOAP

Data e Hora: 2025-11-18 17:49:32
Paciente: 
Diagn√≥stico:
## Hist√≥rico de Diagn√≥stico:
1. Hist√≥rico M√©dico: Apresenta√ß√£o m√©dica sobre benef√≠cios da dieta cetog√™nica e low-carb para diabetes tipo 2, obesidade, psor√≠ase e esclerose m√∫ltipla; n√£o h√° informa√ß√µes de um paciente espec√≠fico.
2.

---

### Chunk 13/30
**Article:** Dose-dependent effect of carbohydrate restriction for type 2 diabetes management: a systematic review and dose-response meta-analysis of randomized controlled trials (2026)
**Journal:** Revista n√£o identificada
**Section:** discussion | **Similarity:** 0.701

swithtype2diabetes(8),anddeterminedthedegreesofcarbohydraterestrictionatwhichtheeffectsizessurpassedthresholdssetasindicating
animportanteffect.Wheneverpossible,weusedself-reporteddietarydatafortheanalyses.Oneofthemainproblemsinimplementinglow-carbohydratedietsisthatitisrelativelyhard
tocompletelyadheretoprescribedcarbohydraterestrictions(40).Previousmeta-analysesdidnotconsiderthedifferencesbetweenprescribedandactualcarbohydrateintakes,andonlyperformed
asensitivityanalysisrestrictingtheanalysestoparticipantswithhighadherencetotheprescribeddiets(8).Althoughself-reporteddietaryintakesaresubjecttomeasurementerror,especially
intrialswhereinparticipantsarenotblinded(105,106),theycanpresentmoreaccurateinformationabouttheamountsofcarbohydrateintakeinthetrialsthancanprescribeddata(40).Weconvertedg/dto%calorie,andtherebyharmonizedthedataacrosstrials.Weincludedsufcienttrialsfordose-responsemeta-analysesforbothmoderate-carbohydrate(39trials)andlow-
carbohydrate(10trials)diets.Ourmeta-analysiswas

---

### Chunk 14/30
**Article:** Dieta Cetog√™nica - Parte II (2024)
**Journal:** Pos Graduacao MFI
**Section:** discussion | **Similarity:** 0.701

ote√≠na preserva massa magra e favorece perda de gordura.
* Meta-an√°lise de RCTs: cetog√™nica de muito baixa caloria vs. low-fat (13 ensaios; >12 meses; n‚âà1.500; 790 cetose; 780 low-fat)
   - Peso: interven√ß√£o cetog√™nica favorecida ao longo de 12 meses; em 36 meses, a diferen√ßa estat√≠stica final n√£o se manteve ap√≥s cessar a interven√ß√£o‚Äîrecupera√ß√£o esperada quando os pacientes retornam ao padr√£o anterior; efic√°cia maior durante ades√£o ativa.
   - Lip√≠dios: HDL aumentou; triglic√©rides reduziram; perfil de LDL melhorou em estudos mais longos (queda ao fim), contrastando com estudos mais curtos que podem mostrar diferen√ßas de LDL.
   - Interpreta√ß√£o: low carb/cetog√™nicas s√£o superiores em risco cardiovascular para pacientes com resist√™ncia insul√≠nica, DM2 e obesidade; ades√£o e estilo de vida determinam a manuten√ß√£o.

---

### Chunk 15/30
**Article:** Dose-dependent effect of carbohydrate restriction for type 2 diabetes management: a systematic review and dose-response meta-analysis of randomized controlled trials (2026)
**Journal:** Revista n√£o identificada
**Section:** results | **Similarity:** 0.694

wasnotconsistentacrossstudyarmsinthetrials.Thereisevidencethatdietswithequalamountsofcarbohydratesanddifferentglycemicindexesmayexertdifferent
effectsoncardiometabolicriskfactors(90).Arecentsystematicreviewofrandomizedtrialsindicatedthatdietswithalowglycemicindexcanexertsmallbutimportantimprovements
incardiometabolicriskfactorsinpatientswithdiabetes(112).However,wehadlimitedevidencetoevaluatethepotentialeffectsofcarbohydratequalityontheresults.Third,according
toouraprioriprotocol(29),wedidnotevaluateadverseeventsinourreview.Previousreviewshavereportednosignicantorclinicallyimportantincreasesinadverseeventsfollowingadherencetolow-carbohydratedietsat6-monthand12-monthfollow-ups(8,14).However,thelong-termeffectsofsuchdietsoncardiovascularandrenaldiseaseshavenotbeenevaluated.

---

### Chunk 16/30
**Article:** Dose-dependent effect of carbohydrate restriction for type 2 diabetes management: a systematic review and dose-response meta-analysis of randomized controlled trials (2026)
**Journal:** Revista n√£o identificada
**Section:** discussion | **Similarity:** 0.692

ion,
accordingtocurrentrecommendations,very-low-carbohydratedietsaregenerallydenedasdietswith‚â§10%or<50g/dcarbohydrateintakes(31,32).Of11trialsthatimplementedavery-low-carbohydratediet(basedonacarbohydrateintake<50g/d)intherecentmeta-analysis(8),1trialwasnotincludedinthepresentmeta-analysisbecausedidnotreportsufcient
informationregardingthepercentageofcarbohydrateintakeinthecontrolgroup(104),andtheother10trials(includedinthepresentreview)wereclassiedashavinglow-carbohydrate
dietswhenweconvertedself-reportedcarbohydrateintakesto%calorie(49,50,52,58,61,77,79,80,83,89).Forexample,
	
	
Getulio Jos√© Mattos Do Amaral Filho - getfilho@yahoo.com.br - CPF: 034.983.039-88

52Jayedietal.in1trialthatevaluatedtheeffectofaprescribedketogenicdiet(20g/d)oncardiometabolicoutcomes,thepercentageofcarbohydrateintakewas13%ofthetotalcalorieintakeoverthefollow-upperiodwhenwelookedattheself-reporteddietarydata
(89).StrengthsandlimitationsofthestudyGivenalargenum

---

### Chunk 17/30
**Article:** Effect of the ketogenic diet on glycemic control, insulin resistance, and lipid metabolism in patients with T2DM: a systematic review and meta-analysis (2026)
**Journal:** Revista n√£o identificada
**Section:** discussion | **Similarity:** 0.687

63‚Äì1164(2019).8.Saslow,L.R.etal.Anonlineinterventioncomparingaverylow-carbohydrateketogenicdietandlifestylerecommendationsversusaplatemethoddietinoverweightindividualswithT2DM:arandomizedcontrolledtrial.J.Med.InternetRes.19,e36(2017).9.Saslow,L.R.etal.Twelve-monthoutcomesofarandomizedtrialofamoderate-carbohydrateversusverylow-carbohydratedietinoverweightadultswithT2DMmellitusorprediabetes.Nutr.Diabetes7,304(2017).10.Meng,Y.etal.EfcacyoflowcarbohydratedietforT2DMmellitusmanage-ment:asystematicreviewandmeta-analysisofrandomizedcontrolledtrials.

---

### Chunk 18/30
**Article:** Dose-dependent effect of carbohydrate restriction for type 2 diabetes management: a systematic review and dose-response meta-analysis of randomized controlled trials (2026)
**Journal:** Revista n√£o identificada
**Section:** results | **Similarity:** 0.685

pactsofvery-low-
carbohydratediets(‚â§10%)inpatientswithtype2diabetes.Theauthors‚Äôresponsibilitieswereasfollows‚ÄìAJ,SS-B:conceivedanddesignedthestudy,conductedthesystematicsearch,readthefulltextsfor
eligibility,evaluatedtrialsforriskofbias;SZ-M,BJ,HS,AM:screened
articles;AJ,SZ-M:extracteddatafromoriginaltrials;AJ:performedthe
analysesandatteststhatalllistedauthorsmeetauthorshipcriteriaandthat
noothersmeetingthecriteriahavebeenomitted;AJ,SZ-M,BJ,YH,ATJ,
SZ-M,HS,AM,FH:contributedtotheinterpretationoftheresultsandwrote
therstdraftofthemanuscript;SS-B:contributedtotheinterpretationofthe
results,criticallyrevisedthemanuscript,andistheguarantor;allauthors:
acknowledgefullresponsibilityfortheanalysesandinterpretationofthe
reportandreadandapprovedthenalmanuscript.Theauthorsreportno
conictsofinterest.DataAvailabilityDatadescribedinthemanuscript,codebook,andanalyticcodewillbemadeavailableuponreasonablerequest.References1.ChoN,ShawJ,KarurangaS,YHuang,daRochaFernandesJ,OhlroggeA,MalandaB.IDFD

---

### Chunk 19/30
**Article:** Dose-dependent effect of carbohydrate restriction for type 2 diabetes management: a systematic review and dose-response meta-analysis of randomized controlled trials (2026)
**Journal:** Revista n√£o identificada
**Section:** discussion | **Similarity:** 0.684

nX,WangJ,YangS,GaoM,CaoL,LiX,HongD,TianS,SunC.Effectoftheketogenicdietonglycemiccontrol,insulinresistance,andlipidmetabolisminpatientswithT2DM:Asystematicreviewandmeta-analysis.NutrDiabetes2020;10(1):38.17.SainsburyE,KizirianNV,PartridgeSR,GillT,ColagiuriS,GibsonAA.Effectofdietarycarbohydraterestrictiononglycemiccontrolinadultswithdiabetes:Asystematicreviewandmeta-analysis.DiabetesResClinPract2018;139:239‚Äì52.18.FanY,DiH,ChenG,MaoX,LiuC.Effectsoflowcarbohydratedietsinindividualswithtype2diabetes:Systematicreviewandmeta-analysis.IntJClinExpMed2016;9(6):11166‚Äì74.19.KodamaS,SaitoK,TanakaS,MakiM,YachiY,SatoM,SugawaraA,TotsukaK,ShimanoH,OhashiY.Inuenceoffatandcarbohydrateproportionsonthemetabolicproleinpatientswithtype2diabetes:Ameta-analysis.DiabetesCare2009;32(5):959‚Äì65.20.McArdleP,GreeneldS,RilstoneS,NarendranP,HaqueMS,GillP.Carbohydraterestrictionforglycaemiccontrolintype2diabetes:Asystematicreviewandmeta-analysis.DiabetMed2019;36(3):335‚Äì48.21.NaudeCE,SchooneesA,SenekalM,Young

---

### Chunk 20/30
**Article:** Dose-dependent effect of carbohydrate restriction for type 2 diabetes management: a systematic review and dose-response meta-analysis of randomized controlled trials (2026)
**Journal:** Revista n√£o identificada
**Section:** results | **Similarity:** 0.684

echanisms,suchasincreasingenergyexpenditure(98).Ourresultsindicatedthatthefavorableeffectsofcarbohydraterestrictiononcardiometabolicoutcomeswerenotmaintained(forFPG,SBP,HDLcholesterol,andtotalcholesterol)ordiminished
substantially(forHbA1c,LDLcholesterol,TG,andbodyweight)atfollow-upslongerthan6months.Althoughweobservedsignicantandimportant(largerthanMCIDthresholds)effects
onlevelsofHbA1c,bodyweight,LDLcholesterol,TG,andSBPatthe6-monthfollow-up,theeffectsofcarbohydraterestrictiondidnotsurpasstheMCIDthresholdssetforanyoutcomes
atlongerfollow-updurations.Theremarkablereductioninthebenetsofrestricted-carbohydratedietsontype2diabetesmanagementwasconsistentlyreportedinpreviousreviews(5,10,14,15,17,19,20,22),andmaybeattributabletothedecreaseinthedegreeofadherencetolow-carbohydratediets(8,99).Ourprespeciedsubgroupanalysessuggestedevidenceofasignicanteffectmodicationbythepercentageofproteinintakeintheinterventionarms,wheretrialsthatimplementedalow-carbohydrateandmoderate-tohigh-proteindiet

---

### Chunk 21/30
**Article:** Dieta Cetog√™nica - Parte II (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.682

rog√™nica do aumento de LDL total em alguns casos.
### 2. Obesidade: mecanismos e resultados com dietas cetog√™nicas
* Mecanismos de perda de peso em cetog√™nica/low carb
   - Menor insulina e maior saciedade de prote√≠nas/gorduras reduzem apetite; corpos cet√¥nicos suprimem apetite.
   - Redu√ß√£o da lipog√™nese e aumento da lip√≥lise, dependentes do balan√ßo cal√≥rico; ingest√£o excessiva de gordura impede emagrecimento.
   - Quociente respirat√≥rio reduzido (VCO2/VO2), indicando maior oxida√ß√£o de gorduras; melhora com a adapta√ß√£o (cetoadapta√ß√£o ~6 semanas; atletas ~6 meses para performance).
   - Maior custo energ√©tico da gliconeog√™nese, sobretudo com menos carboidratos e mais atividade f√≠sica.
   - Efeito t√©rmico da prote√≠na: ~25% das calorias proteicas viram calor; maior prote√≠na preserva massa magra e favorece perda de gordura.
* Meta-an√°lise de RCTs: cetog√™nica de muito baixa caloria vs.

---

### Chunk 22/30
**Article:** Dose-dependent effect of carbohydrate restriction for type 2 diabetes management: a systematic review and dose-response meta-analysis of randomized controlled trials (2026)
**Journal:** Revista n√£o identificada
**Section:** discussion | **Similarity:** 0.682

effectofcarbohydraterestrictiononTG(mmol/L)inpatientswithtype2diabetesatthe12-monthfollow-up(n=13trials).TG,triglyceride.meta-analysisalsoindicatedevidenceofU-shapedeffectsontotalcholesterolandLDLcholesterolatthe6-monthfollow-upandon
bodyweightatthe12-monthfollow-up.Atthe12-monthfollow-up,theeffectofcarbohydraterestrictionwaslimitedtoreductionsinHbA1c,bodyweight,LDLcholesterol,andTG,withthesizes
oftheeffectswellbelowMCIDthresholds.Atfollow-upslongerthan12months,carbohydraterestrictionresultedinasignicantbutunimportantreductioninHbA1c.Theeffectivenessofmoderate-carbohydrate(45%to26%),low-carbohydrate(25%to11%),andvery-low-carbohydrate(‚â§10%)dietsfortype2diabetesmanagementhasbeenevaluatedinseveralmeta-analysesofinterventionstudies.Ourresultsareinlinewiththoseofpreviousreviewsdemonstratingtheshort-termeffectivenessofrestricted-carbohydratedietsinreducingHbA1c
(5,8‚Äì10,14,15,18,20,22),bodyweight(8,14,15,17,18,20,22),serumTG(8‚Äì10,15,17,19,22),andbloodpressure(9,15),aswellasinincreasing

---

### Chunk 23/30
**Article:** Emagrecimento - Parte IV (2024)
**Journal:** Pos Graduacao MFI
**Section:** discussion | **Similarity:** 0.682

. Estrat√©gia Inicial de Emagrecimento: Low-Carb
*   **Restri√ß√£o de Carboidratos Refinados como Primeiro Passo:** A estrat√©gia inicial deve ser a restri√ß√£o de carboidratos refinados (p√£o, macarr√£o), quebrando o h√°bito de consumo excessivo que constitui o principal erro alimentar.
*   **Efic√°cia e Valida√ß√£o Cient√≠fica:** Uma revis√£o de 2015 aponta a dieta de restri√ß√£o de carboidratos como a primeira abordagem para o diabetes. Uma meta-an√°lise de 2021 comprovou a efic√°cia e seguran√ßa de dietas com muito baixo teor de carboidratos (cetog√™nica) para a remiss√£o do diabetes tipo 2.
*   **Mecanismos Fisiol√≥gicos da Dieta Low-Carb:** A abordagem visa ativar vias metab√≥licas ben√©ficas (PGC1-alfa, Sirtu√≠nas), reduzir a inflama√ß√£o (via NF-kappaB), promover saciedade (aumento de PYY, GIP, GLP-1) e melhorar o desempenho mitocondrial.
*   **Papel das Prote√≠nas e Desafios a Longo Prazo:** A adequa√ß√£o de prote√≠nas √© crucial para a saciedade.

---

### Chunk 24/30
**Article:** Effect of the ketogenic diet on glycemic control, insulin resistance, and lipid metabolism in patients with T2DM: a systematic review and meta-analysis (2026)
**Journal:** Revista n√£o identificada
**Section:** discussion | **Similarity:** 0.679

 1558(2002).21.DerSimonian,R.&Laird,N.Meta-analysisinclinicaltrials.ControlClin.Trials7,177‚Äì188(1986).22.McKenzie,A.L.etal.ANovelInterventionIncludingIndividualizedNutritionalRecommendationsReducesHemoglobinA1cLevel,MedicationUse,and
WeightinType2Diabetes.JMIRDiabetes2,e5(2017).23.Yancy,W.S.etal.Alow-carbohydrate,ketogenicdiettotreattype2diabetes.Nutr.Metab.(Lond)2,34(2005).24.Athinarayanan,S.J.etal.Long-termeffectsofanovelcontinuousremotecareinterventionincludingnutritionalketosisforthemanagementofT2DM:a2-yearnon-randomizedclinicaltrial.Front.Endocrinol.10,348(2019).25.Laffel,L.Ketonebodies:areviewofphysiology,pathophysiologyandappli-cationofmonitoringtodiabetes.DiabetesMetab.Res.Rev.15,412‚Äì426(1999).26.Gershuni,V.M.,Yan,S.L.&Medici,V.Nutritionalketosisforweightmanage-mentandreversalofmetabolicsyndrome.Curr.Nutr.Rep.7,97‚Äì106(2018).27.Yancy,W.S.,Vernon,M.C.&Westman,E.C.Apilottrialofalow-carbohydrate,ketogenicdietinpatientswithT2DM.Metab.Syndr.Relat.Disord.1,239‚Äì243(2003).28.Bol

---

### Chunk 25/30
**Article:** Dieta Cetog√™nica - Parte II (2024)
**Journal:** Pos Graduacao MFI
**Section:** conclusion | **Similarity:** 0.675

e; ades√£o e estilo de vida determinam a manuten√ß√£o.
* Metaregress√£o sobre prote√≠na/carboidrato na restri√ß√£o energ√©tica (87 estudos; ~1.000 kcal/dia)
   - Defini√ß√µes: low carb como 35‚Äì41% das calorias de carboidratos em dietas hipocal√≥ricas; compara√ß√£o com >42% de carboidratos.
   - Tempo e composi√ß√£o corporal:
     - <12 semanas: perda adicional de 1,74 kg; perda de massa magra ~0,6 kg; redu√ß√£o de gordura corporal de 1% e de massa gorda de 2 kg.
     - >12 semanas: perda adicional de 6 kg; ganho de massa magra de 1,74 kg; redu√ß√£o de gordura corporal de 3,5% e de massa gorda de 5 kg.
   - Papel da prote√≠na: ingest√£o ‚â•1 g/kg/dia associada a reten√ß√£o/ganho de massa magra‚Äîmesmo <12 semanas, ganho de ~0,6 kg; >12 semanas, +1,2 kg; recomenda√ß√£o m√≠nima ‚â•1 g/kg/dia em dietas muito hipocal√≥ricas.
   - Conclus√£o: low carb com prote√≠na alta favorece composi√ß√£o corporal independentemente da ingest√£o cal√≥rica, sugerindo vantagem metab√≥lica.

---

### Chunk 26/30
**Article:** Dose-dependent effect of carbohydrate restriction for type 2 diabetes management: a systematic review and dose-response meta-analysis of randomized controlled trials (2026)
**Journal:** Revista n√£o identificada
**Section:** discussion | **Similarity:** 0.674

ow-carbohydratedietiseffectiveasanalternativetherapyforpatientswithtype2diabetes.InternMed2014;53(1):13‚Äì9.93.ZadehMAM,KargarfardM,MarandiSM,HabibiA.Dietsalongwithintervaltrainingregimesimprovesinammatory&anti-inammatoryconditioninobesitywithtype2diabetessubjects.JDiabetesMetabDis2018;17(2):253‚Äì67.94.PinartM,JeranS,BoeingH,Stelmach-MardasM,StandlM,SchulzH,HarrisC,vonBergA,HerberthG,KoletzkoS.DietarymacronutrientcompositioninrelationtocirculatingHDLandnon-HDLcholesterol:Afederatedindividual-levelanalysisofcross-
sectionaldatafromadolescentsandadultsin8Europeanstudies.J
Nutr2021;151(8):2317‚Äì29.95.MensinkRP,WHO.Effectsofsaturatedfattyacidsonserumlipidsandlipoproteins:Asystematicreviewandregressionanalysis.Geneva:
WorldHealthOrganization;2016.96.ZhaoH,SongA,ZhengC,WangM,SongG.Effectsofplantproteinandanimalproteinonlipidprole,bodyweightandbodymassindex
onpatientswithhypercholesterolemia:Asystematicreviewandmeta-
analysis.ActaDiabetol2020;57(10):1169‚Äì80.97.LiSS,BlancoMejiaS,LytvynL

---

### Chunk 27/30
**Article:** Dose-dependent effect of carbohydrate restriction for type 2 diabetes management: a systematic review and dose-response meta-analysis of randomized controlled trials (2026)
**Journal:** Revista n√£o identificada
**Section:** other | **Similarity:** 0.672

nthetreatmentoftype2diabetes:A12month
randomisedcontrolledtrial.Diabetologia2011;54(4):731‚Äì40.68.LiuK,WangB,ZhouR,LangHD,RanL,WangJ,LiL,KangC,ZhuXH,ZhangQY,etal.Effectofcombineduseofalow-carbohydrate,high-proteindietwithomega-3polyunsaturatedfatty
acidsupplementationonglycemiccontrolinnewlydiagnosedtype2
	
	
Getulio Jos√© Mattos Do Amaral Filho - getfilho@yahoo.com.br - CPF: 034.983.039-88

Carbohydraterestrictionindiabetes55diabetes:Arandomized,double-blind,parallel-controlledtrial.AmJClinNutr2018;108(2):256‚Äì65.69.LugerM,HolsteinB,SchindlerK,KruschitzR,LudvikB.Feasibilityandefcacyofanisocalorichigh-proteinvs.standarddietoninsulinrequirement,bodyweightandmetabolicparametersinpatientswith
type2diabetesoninsulintherapy.ExpClinEndocrinolDiabetes2013;121(5):286‚Äì94.70.MayerSB,JeffreysAS,OlsenMK,McDufeJR,FeinglosMN,YancyWSJr.TwodietswithdifferenthaemoglobinA1candantiglycaemic
medicationeffectsdespitesimilarweightlossintype2diabetes.DiabetesO

---

### Chunk 28/30
**Article:** Dose-dependent effect of carbohydrate restriction for type 2 diabetes management: a systematic review and dose-response meta-analysis of randomized controlled trials (2026)
**Journal:** Revista n√£o identificada
**Section:** results | **Similarity:** 0.670

heshort-termeffectivenessofrestricted-carbohydratedietsinreducingHbA1c
(5,8‚Äì10,14,15,18,20,22),bodyweight(8,14,15,17,18,20,22),serumTG(8‚Äì10,15,17,19,22),andbloodpressure(9,15),aswellasinincreasingHDLcholesterol(5,8‚Äì10,15,18,19).Forserumcholesterol,theresultsareinconsistent.Althoughmostreviewsindicatedthattherewerenodifferencesbetweenlow-carbohydratedietsandotherdiets,mostlylow-fatdiets,in
reducingserumtotalcholesterol(5,15,17,20,22),arecentsystematicreviewindicatedasignicantincreaseatthe6-monthfollow-up(14).However,ourdose-responsemeta-analysisindicatedaU-shapedeffectfortotalcholesterolatthe6-monthfollow-up,withanupwardcurveatcarbohydrateintakeslessthan40%.TherewasalsoaslightupwardcurveforLDLcholesterol
atcarbohydrateintakeslessthan35%atthe6-monthfollow-up.ThenullndingsobservedinpreviousreviewscanbeexplainedbytheU-shapedeffect,whereserumtotalcholesterolincreased
atcarbohydrateintakeslowerthan40%.Theintakeofdietaryfatincreasesalongwiththedecreaseincarbohydrateintake,andthiscanpa

---

### Chunk 29/30
**Article:** Dieta Cetog√™nica - Parte I (2024)
**Journal:** Pos Graduacao MFI
**Section:** other | **Similarity:** 0.670

< 20 g de carboidratos/dia, 0,8‚Äì1 g/kg/d de prote√≠na e 70‚Äì90% de calorias em gordura; monitorar GKI visando < 3 (ideal < 1); ajustar dieta, exerc√≠cio, sono e estresse.
- [ ] 6. Implementar protocolo de medi√ß√£o di√°ria de glicose e cetona no mesmo hor√°rio; registrar valores e ajustar conforme metas de GKI.
- [ ] 7. Estabelecer plano de hidrata√ß√£o (‚â• 2 L/d na fase inicial) e suplementa√ß√£o de eletr√≥litos (sal, pot√°ssio, magn√©sio; considerar sal light e eletr√≥litos comerciais); monitorar PA e rever diur√©ticos/anti-hipertensivos.
- [ ] 8. Selecionar TCM/MCT com predomin√¢ncia de C8 e C10, evitando C6; testar toler√¢ncia e ajustar dose para elevar cetonemia sem desconforto GI.
- [ ] 9. Programar suplementa√ß√£o pedi√°trica (c√°lcio e vitamina D) e acompanhamento obrigat√≥rio por m√©dico e nutricionista, monitorando crescimento.
- [ ] 10.

---

### Chunk 30/30
**Article:** Dose-dependent effect of carbohydrate restriction for type 2 diabetes management: a systematic review and dose-response meta-analysis of randomized controlled trials (2026)
**Journal:** Revista n√£o identificada
**Section:** other | **Similarity:** 0.668

gnicantandimportant
improvementsincardiometabolicoutcomesatshort-termfollow-ups.WeindicatedthattherewereinverselinearassociationsbetweencarbohydratepercentagesandlevelsofHbA1c,FPG,
bodyweight,TG,andSBPatthe6-monthfollow-up,withthemagnitudesoftheeffectsexceedingMCIDthresholdsforHbA1c,bodyweight,LDLcholesterol,TG,andSBP.There
wasevidenceofU-shapedeffectsontotalcholesterolandLDLcholesterolatthe6-monthfollow-upandonbodyweightatthe
	
	
Getulio Jos√© Mattos Do Amaral Filho - getfilho@yahoo.com.br - CPF: 034.983.039-88

Carbohydraterestrictionindiabetes5312-monthfollow-up.Thefavorableeffectsoflow-carbohydratedietsdiminishedremarkablyatthe12-monthfollow-upandwerenotmaintainedatfollow-upslongerthan12months.Furtherwell-designedtrialsareneededtoaddresstheimpactsofvery-low-
carbohydratediets(‚â§10%)inpatientswithtype2diabetes.Theauthors‚Äôresponsibilitieswereasfollows‚ÄìAJ,SS-B:conceivedanddesignedthestudy,conductedthesystematicsearch,readthefulltextsfor

---

